Views & Analysis A spotlight on patient-provider dialogue Patient-provider communication impacts both short- and long-term outcomes.
Views & Analysis Does your brand need behavioural science? Behavioural science has become a buzzword for pharma. Why? Because behaviour is a barrier to meeting brand objectives.
Views & Analysis Building a new type of pharmaceutical company – a vision for... The definition of healthcare has become incredibly diverse since the turn of the century.
Views & Analysis Getting inspired at South by Southwest Following this year’s South by Southwest (SXSW) conference in Austin, Texas, it occurred to me that the progression of SXSW matches what I’ve seen – and
News Merck rare tumour drug Ezmekly backed for NHS use Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
